A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06055361 · RECRUITING
Trial details
- NCT number
- NCT06055361
- Sponsor
- Brexogen Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-18
- Primary completion
- 2026-03-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.